1211516-07-2 Usage
Uses
Used in Pharmaceutical Industry:
2-chloro-4-iodo-5-methoxypyridine is used as a building block for the synthesis of pharmaceuticals, contributing to the development of new drugs with potential therapeutic applications. Its unique structure allows for the creation of diverse chemical entities with specific biological activities.
Used in Agrochemical Industry:
In the agrochemical sector, 2-chloro-4-iodo-5-methoxypyridine is utilized as a key intermediate in the synthesis of agrochemicals, such as pesticides and herbicides. Its reactivity enables the production of compounds with targeted effects on pests and weeds, enhancing crop protection and yield.
Used in Organic Chemistry:
2-chloro-4-iodo-5-methoxypyridine is employed as a versatile intermediate in organic chemistry for the synthesis of various organic compounds. Its distinct functional groups facilitate multiple reaction pathways, leading to the formation of a wide range of chemical products with different applications.
Due to its potential hazards, 2-chloro-4-iodo-5-methoxypyridine is typically handled and stored in a controlled environment to ensure safety and minimize risks during its use in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1211516-07-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,1,5,1 and 6 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1211516-07:
(9*1)+(8*2)+(7*1)+(6*1)+(5*5)+(4*1)+(3*6)+(2*0)+(1*7)=92
92 % 10 = 2
So 1211516-07-2 is a valid CAS Registry Number.
1211516-07-2Relevant academic research and scientific papers
SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS
-
Paragraph 01339; 01340, (2015/04/28)
The invention is concerned with the compounds of formula I or II: and salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I or II as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.
COMPOUNDS AND METHODS OF USE
-
Paragraph 0181, (2015/07/16)
This disclosure provides compounds and compositions and methods of using those compounds and compositions to treat diseases and disorders associated with excessive transforming growth factor-beta (TGFβ) activity. This disclosure also provides methods of using the compounds in combination with one or more cancer immunotherapies.
Pyrazolopyrrolidine compounds
-
Page/Page column 201, (2013/06/27)
The invention relates to compounds of formula (I) as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of MDM2 and/or MDM4, and combinations comprising such compounds.
